| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33342-314-11 | 33342-314 | HUMAN PRESCRIPTION DRUG | Propylthiouracil | Propylthiouracil | TABLET | ORAL | 20230510 | N/A | ANDA | ANDA208867 | Macleods Pharmaceuticals Limited | PROPYLTHIOURACIL | 50 mg/1 | 100 TABLET in 1 BOTTLE (33342-314-11) |
| 33342-314-12 | 33342-314 | HUMAN PRESCRIPTION DRUG | Propylthiouracil | Propylthiouracil | TABLET | ORAL | 20230510 | N/A | ANDA | ANDA208867 | Macleods Pharmaceuticals Limited | PROPYLTHIOURACIL | 50 mg/1 | 10 BLISTER PACK in 1 CARTON (33342-314-12) / 10 TABLET in 1 BLISTER PACK |
| 33342-314-44 | 33342-314 | HUMAN PRESCRIPTION DRUG | Propylthiouracil | Propylthiouracil | TABLET | ORAL | 20230510 | N/A | ANDA | ANDA208867 | Macleods Pharmaceuticals Limited | PROPYLTHIOURACIL | 50 mg/1 | 1000 TABLET in 1 BOTTLE (33342-314-44) |